1. Home
  2. NDLS vs ELUT Comparison

NDLS vs ELUT Comparison

Compare NDLS & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Noodles & Company

NDLS

Noodles & Company

N/A

Current Price

$0.60

Market Cap

29.8M

ML Signal

N/A

Logo Elutia Inc.

ELUT

Elutia Inc.

N/A

Current Price

$0.51

Market Cap

25.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NDLS
ELUT
Founded
1995
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.8M
25.2M
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
NDLS
ELUT
Price
$0.60
$0.51
Analyst Decision
Hold
Strong Buy
Analyst Count
1
2
Target Price
N/A
$7.00
AVG Volume (30 Days)
644.9K
261.3K
Earning Date
11-05-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$494,087,000.00
$21,746,000.00
Revenue This Year
$2.18
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
24.08
52 Week Low
$0.55
$0.53
52 Week High
$1.74
$4.84

Technical Indicators

Market Signals
Indicator
NDLS
ELUT
Relative Strength Index (RSI) 37.10 24.92
Support Level $0.76 $0.66
Resistance Level $1.08 $0.72
Average True Range (ATR) 0.12 0.05
MACD -0.03 -0.00
Stochastic Oscillator 0.48 3.82

Price Performance

Historical Comparison
NDLS
ELUT

About NDLS Noodles & Company

Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.

About ELUT Elutia Inc.

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

Share on Social Networks: